# Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS

> **NCT01203371** · PHASE3 · WITHDRAWN · sponsor: **Apsen Farmaceutica S.A.**

## Conditions studied

- Hyperplasia

## Interventions

- **DRUG:** Naftopidil
- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT01203371
- **Lead sponsor:** Apsen Farmaceutica S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-01-01
- **Primary completion:** 2011-09-01
- **Final completion:** 2012-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01203371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01203371, "Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01203371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*